메인콘텐츠로 건너뛰기

GSE41994

Breat cancer dataset (Cancer Res. 2013, 107 patients)

SUBTYPE SUBTYPE2 SUBTYPE3 age at diagnosis age at start therapy disease progression (event) disease relapse (event) disease-free interval (months) er status gender grade her2 status location menopausal status at start therapy pik3ca status pr status time-to-progession (months) tissue treatment type tumor type
GSM1029704 ER+ ER+ ER+ 82 84 0 1 31 positive female 2 NaN breast post wildtype negative 8 breast anastrozole invasive ductal carcinoma
GSM1029705 ER+ ER+ ER+ 69 71 0 1 31 positive female 2 negative breast post E545K positive 38 breast letrozole invasive ductal carcinoma
GSM1029706 NaN NaN NaN 72 76 1 1 43 negative female 3 NaN breast post wildtype negative 3 breast letrozole invasive ductal carcinoma
GSM1029707 ER+ ER+ ER+ 44 48 0 1 50 positive female 2 negative breast post E545K positive 16 breast anastrozole invasive ductal carcinoma
GSM1029708 ER+ ER+ ER+ 51 54 1 1 30 positive female 3 negative breast pre wildtype positive 3 breast letrozole invasive ductal carcinoma
GSM1029709 ER+ ER+ ER+ 63 66 1 1 0 positive female 2 NaN breast post wildtype NaN 2 breast anastrozole invasive ductal carcinoma
GSM1029710 ER+ ER+ ER+ 70 78 1 1 113 positive female NaN negative breast post wildtype positive 18 breast anastrozole invasive ductal carcinoma
GSM1029711 ER+ ER+ ER+ 51 59 1 1 112 positive female 3 negative breast post H1047R positive 53 breast anastrozole invasive ductal carcinoma
GSM1029712 ER+ ER+ ER+ 76 81 1 1 43 positive female NaN NaN breast post wildtype negative 10 breast anastrozole invasive ductal carcinoma
GSM1029713 NaN NaN NaN 51 58 1 1 87 NaN female NaN NaN breast post H1047R negative 5 breast anastrozole invasive ductal carcinoma
GSM1029714 ER+ ER+ ER+ 68 80 0 1 141 positive female 3 NaN breast post wildtype positive 25 breast letrozole invasive ductal carcinoma
GSM1029715 ER+ ER+ ER+ 56 64 1 1 111 positive female 2 NaN breast post H1047R positive 53 breast letrozole invasive ductal carcinoma
GSM1029716 ER+ ER+ ER+ 64 73 1 1 120 positive female 2 negative breast post wildtype positive 26 breast letrozole invasive ductal carcinoma
GSM1029717 ER+ ER+ ER+ 76 79 1 1 40 positive female 1 NaN breast post wildtype positive 30 breast anastrozole invasive ductal carcinoma
GSM1029718 ER+ ER+ ER+ 83 85 0 1 37 positive female 1 negative breast post H1047R positive 2 breast anastrozole invasive ductal carcinoma
GSM1029719 ER+ ER+ ER+ 71 76 1 1 67 positive female 2 negative breast post wildtype positive 7 breast anastrozole invasive ductal carcinoma
GSM1029720 ER+ ER+ ER+ 58 59 1 1 23 positive female NaN NaN breast post wildtype positive 8 breast anastrozole invasive ductal carcinoma
GSM1029721 ER+ ER+ ER+ 60 61 1 1 18 positive female 3 negative breast post wildtype positive 10 breast anastrozole invasive ductal carcinoma
GSM1029722 ER+ ER+ ER+ 67 72 0 1 70 positive female 2 negative breast post wildtype positive 2 breast letrozole invasive ductal carcinoma
GSM1029723 ER+ ER+ ER+ NaN 82 0 1 59 positive female 2 negative breast post wildtype positive 1 breast letrozole invasive ductal carcinoma
GSM1029724 ER+ ER+ ER+ 67 70 1 1 46 positive female 2 negative breast post wildtype positive 4 breast anastrozole invasive ductal carcinoma
GSM1029725 ER+ ER+ ER+ 49 51 1 1 29 positive female 3 negative breast post H1047R positive 6 breast anastrozole invasive ductal carcinoma
GSM1029726 HER2+ ER+ ER+/HER2+ 63 66 1 1 45 positive female 3 positive breast post wildtype negative 21 breast anastrozole invasive ductal carcinoma
GSM1029727 ER+ ER+ ER+ 65 67 1 1 37 positive female 3 negative breast post wildtype negative 12 breast anastrozole invasive ductal carcinoma
GSM1029728 ER+ ER+ ER+ 78 83 1 1 66 positive female NaN negative breast post H1047R positive 13 breast anastrozole invasive ductal carcinoma
GSM1029729 HER2+ ER+ ER+/HER2+ 45 51 1 1 82 positive female 3 positive breast post H1047R positive 11 breast letrozole invasive ductal carcinoma
GSM1029730 ER+ ER+ ER+ 51 56 1 1 63 positive female 1 negative breast post wildtype positive 10 breast anastrozole invasive ductal carcinoma
GSM1029731 ER+ ER+ ER+ 58 59 1 1 24 positive female 3 negative breast post wildtype negative 10 breast exemestane invasive ductal carcinoma
GSM1029732 ER+ ER+ ER+ 52 54 1 1 24 positive female 2 negative breast post wildtype negative 8 breast anastrozole invasive ductal carcinoma
GSM1029733 ER+ ER+ ER+ 62 64 1 1 36 positive female 3 negative breast post wildtype positive 13 breast letrozole invasive ductal carcinoma
GSM1029734 ER+ ER+ ER+ 55 61 1 1 78 positive female 3 negative breast post wildtype negative 12 breast anastrozole invasive ductal carcinoma
GSM1029735 HER2+ ER+ ER+/HER2+ 51 54 0 1 39 positive female 2 positive breast post H1047R positive 56 breast letrozole invasive ductal carcinoma
GSM1029736 ER+ ER+ ER+ 56 58 1 1 40 positive female 2 negative breast post wildtype NaN 14 breast letrozole invasive ductal carcinoma
GSM1029737 ER+ ER+ ER+ 84 86 1 1 33 positive female 2 negative breast post H1047R positive 4 breast letrozole invasive ductal carcinoma
GSM1029738 HER2+ ER+ ER+/HER2+ 78 80 1 1 35 positive female 3 positive breast post H1047R positive 8 breast exemestane invasive ductal carcinoma
GSM1029739 ER+ ER+ ER+ 69 71 0 1 23 positive female 2 negative breast post H1047R positive 25 breast letrozole invasive ductal carcinoma
GSM1029740 ER+ ER+ ER+ 74 73 1 1 0 positive female 2 negative breast post wildtype positive 16 breast anastrozole invasive ductal carcinoma
GSM1029741 ER+ ER+ ER+ 62 64 1 1 25 positive female 3 negative breast post wildtype negative 3 breast letrozole invasive ductal carcinoma
GSM1029742 ER+ ER+ ER+ 67 69 0 1 31 positive female 1 negative breast post wildtype positive 18 breast anastrozole invasive ductal carcinoma
GSM1029743 ER+ ER+ ER+ 50 49 1 1 0 positive female NaN negative breast pre wildtype negative 12 breast letrozole invasive ductal carcinoma
GSM1029744 ER+ ER+ ER+ 59 58 1 1 0 positive female 1 negative breast post wildtype positive 26 breast letrozole invasive ductal carcinoma
GSM1029745 ER+ ER+ ER+ 55 54 0 1 0 positive female NaN negative breast post wildtype negative 11 breast letrozole invasive ductal carcinoma
GSM1029746 ER+ ER+ ER+ 75 76 1 1 24 positive female 2 negative breast post wildtype positive 26 breast letrozole invasive ductal carcinoma
GSM1029747 ER+ ER+ ER+ 51 54 1 1 30 positive female 3 NaN breast NaN wildtype positive 3 breast letrozole invasive ductal carcinoma
GSM1029748 ER+ ER+ ER+ 63 67 1 1 47 positive female 3 NaN breast post H1047R positive 28 breast anastrozole invasive ductal carcinoma
GSM1029749 NaN NaN NaN 82 85 1 1 35 negative female 1 NaN breast post wildtype negative 14 breast anastrozole invasive ductal carcinoma
GSM1029750 ER+ ER+ ER+ 52 57 1 1 29 positive female 3 negative breast post wildtype positive 6 breast anastrozole invasive ductal carcinoma
GSM1029751 ER+ ER+ ER+ 61 76 0 1 186 positive female NaN NaN breast post wildtype positive 31 breast anastrozole invasive ductal carcinoma
GSM1029752 ER+ ER+ ER+ 48 58 1 1 102 positive female 1 NaN breast post H1047R positive 52 breast anastrozole invasive ductal carcinoma
GSM1029753 NaN NaN NaN 69 72 1 1 41 negative female 2 NaN breast post wildtype negative 11 breast anastrozole invasive ductal carcinoma
GSM1029754 NaN NaN NaN 53 57 1 NaN NaN NaN female NaN NaN breast post wildtype NaN 6 breast anastrozole invasive ductal carcinoma
GSM1029755 ER+ ER+ ER+ 59 62 0 1 41 positive female 2 NaN breast post wildtype negative 11 breast letrozole invasive ductal carcinoma
GSM1029756 ER+ ER+ ER+ 78 80 1 1 24 positive female 3 NaN breast post H1047R positive 17 breast anastrozole invasive ductal carcinoma
GSM1029757 ER+ ER+ ER+ 58 68 1 1 123 positive female NaN NaN breast post wildtype positive 7 breast letrozole invasive ductal carcinoma
GSM1029758 ER+ ER+ ER+ 73 76 1 1 24 positive female 2 negative breast post E545K positive 30 breast exemestane invasive ductal carcinoma
GSM1029759 ER+ ER+ ER+ 69 70 1 1 11 positive female 2 negative breast post wildtype positive 2 breast exemestane invasive ductal carcinoma
GSM1029760 ER+ ER+ ER+ 56 56 1 1 0 positive female 2 negative breast post H1047R negative 18 breast anastrozole invasive ductal carcinoma
GSM1029761 ER+ ER+ ER+ 50 51 1 1 18 positive female 3 negative breast post wildtype positive 14 breast exemestane invasive ductal carcinoma
GSM1029762 ER+ ER+ ER+ 34 35 0 1 14 positive female 2 negative breast post wildtype positive NaN breast letrozole invasive ductal carcinoma
GSM1029763 ER+ ER+ ER+ 56 64 NaN 1 7 positive female 3 negative breast post wildtype negative NaN breast exemestane invasive ductal carcinoma
GSM1029764 HER2+ ER+ ER+/HER2+ 37 NaN NaN NaN NaN positive female NaN positive breast NaN wildtype positive NaN breast NaN invasive ductal carcinoma
GSM1029765 ER+ ER+ ER+ 80 88 NaN 1 0 positive female 1 NaN breast post NaN negative NaN breast exemestane invasive ductal carcinoma
GSM1029766 ER+ ER+ ER+ 76 79 0 1 36 positive female 2 negative breast post wildtype positive 30 breast exemestane invasive ductal carcinoma
GSM1029767 ER+ ER+ ER+ 67 67 1 1 28 positive female 1 negative breast post wildtype positive 11 breast exemestane invasive ductal carcinoma
GSM1029768 HER2+ ER+ ER+/HER2+ 55 60 1 1 46 positive female 3 positive breast post wildtype negative NaN breast anastrozole invasive ductal carcinoma
GSM1029769 ER+ ER+ ER+ 60 62 1 1 16 positive female 3 NaN breast post wildtype negative 12 breast anastrozole invasive ductal carcinoma
GSM1029770 ER+ ER+ ER+ 71 76 1 1 53 positive female 2 NaN breast post wildtype negative 39 breast anastrozole invasive ductal carcinoma
GSM1029771 NaN NaN NaN 35 37 1 1 25 negative female 3 NaN breast post wildtype positive 5 breast exemestane invasive ductal carcinoma
GSM1029772 ER+ ER+ ER+ 85 88 NaN 1 40 positive female 3 negative breast post wildtype positive NaN breast tamoxifen invasive ductal carcinoma
GSM1029773 ER+ ER+ ER+ 41 43 0 1 27 positive female 2 negative breast NaN wildtype positive NaN breast letrozole invasive ductal carcinoma
GSM1029774 ER+ ER+ ER+ 77 79 1 1 14 positive female 2 NaN breast post wildtype negative 13 breast anastrozole invasive ductal carcinoma
GSM1029775 ER+ ER+ ER+ 52 56 1 1 49 positive female 2 negative breast post E542K positive 31 breast letrozole invasive ductal carcinoma
GSM1029776 NaN NaN NaN 70 76 1 1 72 negative female 2 NaN breast post wildtype NaN 3 breast anastrozole invasive ductal carcinoma
GSM1029777 ER+ ER+ ER+ 41 44 1 1 34 positive female 3 negative breast na E542K positive 8 breast anastrozole invasive ductal carcinoma
GSM1029778 HER2+ ER+ ER+/HER2+ 32 44 0 1 131 positive female 1 positive breast pre E542K positive 47 breast letrozole invasive ductal carcinoma
GSM1029779 ER+ ER+ ER+ 36 54 1 1 219 positive female 3 negative breast pre H1047R positive 27 breast anastrozole invasive ductal carcinoma
GSM1029780 ER+ ER+ ER+ 44 48 1 1 48 positive female 2 negative breast post H1047R positive 6 breast tamoxifen invasive ductal carcinoma
GSM1029781 ER+ ER+ ER+ 44 47 1 1 33 positive female 2 negative breast post wildtype positive 10 breast anastrozole invasive ductal carcinoma
GSM1029782 ER+ ER+ ER+ 68 72 1 1 44 positive female 2 negative breast post wildtype positive 10 breast anastrozole invasive ductal carcinoma
GSM1029783 ER+ ER+ ER+ 44 47 1 1 37 positive female 1 negative breast pre wildtype negative 19 breast exemestane invasive ductal carcinoma
GSM1029784 HER2+ ER+ ER+/HER2+ 76 78 1 1 15 positive female 2 positive breast post wildtype negative 7 breast exemestane invasive ductal carcinoma
GSM1029785 ER+ ER+ ER+ 75 79 1 1 45 positive female 2 negative breast post wildtype positive 7 breast exemestane invasive ductal carcinoma
GSM1029786 ER+ ER+ ER+ 55 56 1 1 10 positive female 3 NaN breast post wildtype positive 4 breast anastrozole invasive ductal carcinoma
GSM1029787 ER+ ER+ ER+ 60 62 1 1 23 positive female 3 NaN breast post wildtype positive 3 breast anastrozole invasive ductal carcinoma
GSM1029788 ER+ ER+ ER+ 63 77 0 1 110 positive female NaN NaN breast post wildtype positive 25 breast letrozole invasive ductal carcinoma
GSM1029789 HER2+ HER2+ ER-/HER2+ 43 49 1 1 76 negative female NaN positive breast post H1047R negative 5 breast anastrozole invasive ductal carcinoma
GSM1029790 ER+ ER+ ER+ 38 47 1 1 100 positive female 2 NaN breast post H1047R positive 6 breast anastrozole invasive ductal carcinoma
GSM1029791 ER+ ER+ ER+ 69 71 1 1 24 positive female 2 negative breast post wildtype positive 29 breast anastrozole invasive ductal carcinoma
GSM1029792 ER+ ER+ ER+ 76 NaN NaN NaN NaN positive female 2 negative breast post wildtype positive NaN breast NaN invasive ductal carcinoma
GSM1029793 ER+ ER+ ER+ 80 84 1 1 39 positive female 2 negative breast post E545K positive 2 breast exemestane invasive ductal carcinoma
GSM1029794 ER+ ER+ ER+ 49 55 1 1 76 positive female 2 negative breast post E545K positive 8 breast exemestane invasive ductal carcinoma
GSM1029795 ER+ ER+ ER+ 65 68 1 1 42 positive female 3 negative breast post wildtype negative 6 breast anastrozole invasive ductal carcinoma
GSM1029796 ER+ ER+ ER+ 33 35 1 1 27 positive female 2 negative breast pre wildtype negative 5 breast anastrozole invasive ductal carcinoma
GSM1029797 ER+ ER+ ER+ 50 54 1 1 49 positive female 3 NaN breast post H1047R positive 11 breast exemestane invasive ductal carcinoma
GSM1029798 ER+ ER+ ER+ 58 64 1 1 66 positive female NaN NaN breast post wildtype negative 17 breast anastrozole invasive ductal carcinoma
GSM1029799 ER+ ER+ ER+ 48 57 0 NaN NaN positive female 3 NaN breast post wildtype negative 6 breast anastrozole invasive ductal carcinoma
GSM1029800 ER+ ER+ ER+ 32 35 1 1 9 positive female 3 negative breast pre wildtype positive 14 breast letrozole invasive ductal carcinoma
GSM1029801 ER+ ER+ ER+ 74 80 1 1 83 positive female 2 NaN breast post wildtype positive 24 breast letrozole invasive ductal carcinoma
GSM1029802 ER+ ER+ ER+ 81 81 1 1 11 positive female 3 negative breast post wildtype positive 4 breast letrozole invasive ductal carcinoma
GSM1029803 ER+ ER+ ER+ 79 81 1 1 1 positive female 2 negative breast post wildtype negative 5 breast exemestane invasive ductal carcinoma
GSM1029804 ER+ ER+ ER+ 75 75 NaN 1 0 positive female 2 negative breast post wildtype positive NaN breast exemestane invasive ductal carcinoma
GSM1029805 ER+ ER+ ER+ 46 51 0 1 0 positive female 2 NaN breast post NaN positive NaN breast exemestane invasive ductal carcinoma
GSM1029806 HER2+ ER+ ER+/HER2+ 73 73 1 1 0 positive female 3 positive breast post wildtype positive 18 breast anastrozole invasive ductal carcinoma
GSM1029807 ER+ ER+ ER+ 78 78 1 1 0 positive female 2 negative breast post wildtype negative 5 breast anastrozole invasive ductal carcinoma
GSM1029808 ER+ ER+ ER+ 69 69 1 1 0 positive female 3 negative breast post wildtype positive 2 breast exemestane invasive ductal carcinoma
GSM1029809 HER2+ HER2+ ER-/HER2+ 51 52 1 1 15 negative female 2 positive breast post wildtype negative 11 breast letrozole invasive ductal carcinoma
GSM1029810 TNBC TNBC TNBC 48 50 1 1 17 negative female 3 negative breast post wildtype negative 6 breast anastrozole invasive ductal carcinoma